SEC 13F Intelligence

Managers / Q1 2026

WASHINGTON UNIVERSITY

CIK 0000903603 · CAMPUS BOX NUMBER 1058, ONE BROOKINGS DRIVE, ST LOUIS, MO, 63130-4899 · 314-935-5152

Reported Value
$160M
Q1 2026
Positions
2
Filings on Record
22
2019–present window
Filed
May 6, 2026
original filing

Summary

Washington University reported $160M in U.S.-listed holdings across 2 positions for Q1 2026.

The portfolio is heavily concentrated: Nu alone accounts for 94.8% of reported value.

Compared with Q4 2025, the fund opened 0 new positions and exited 3.

Portfolio Metrics

Turnover
0.0%
vs prior filed quarter
Largest Position
+94.8%
Nu

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’20: $134MQ4 ’20Q1 ’21: $116MQ2 ’21: $280MQ3 ’21: $344MQ3 ’21Q4 ’21: $357MQ1 ’22: $277MQ2 ’22: $270MQ2 ’22Q3 ’22: $296MQ2 ’23: $267MQ3 ’23: $278MQ3 ’23Q4 ’23: $203MQ1 ’24: $270MQ2 ’24: $220MQ2 ’24Q3 ’24: $154MQ4 ’24: $118MQ1 ’25: $111MQ1 ’25Q2 ’25: $121MQ3 ’25: $179MQ4 ’25: $198MQ4 ’25Q1 ’26: $160Mfilingsflow.com

Portfolio Composition

By security type
Other: 94.8%Common Stock: 5.2%
  • Other · 94.8% · $152M
  • Common Stock · 5.2% · $8M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
MRNAMODERNA INCSOLD OUT150.0K0$4M$0
RBRKRUBRIK INCSOLD OUT50.5K0$4M$0
FIGFIGMA INCSOLD OUT26.5K0$992,061$0
NU HOLDINGS LTDHELD+010.57M$25M$152M
MAZEMAZE THERAPEUTICS INCHELD+0280.8K$3M$8M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

2 positions
#IssuerClass% PortfolioValueShares
1NU HOLDINGS LTDORD SHS CL A94.77%$152M10.57M
2MAZEMAZE THERAPEUTICS INChistory →COM5.23%$8M280.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$160M2May 6, 202613F-HRchanges · EDGAR ↗
Q4 2025$198M5Jan 16, 202613F-HRchanges · EDGAR ↗
Q3 2025$179M3Nov 3, 202513F-HRchanges · EDGAR ↗
Q2 2025$121M4Jul 18, 202513F-HRchanges · EDGAR ↗
Q1 2025$111M2May 5, 202513F-HRchanges · EDGAR ↗
Q4 2024$118M3Jan 24, 202513F-HRchanges · EDGAR ↗
Q3 2024$154M4Oct 29, 202413F-HRchanges · EDGAR ↗
Q2 2024$220M3Aug 5, 202413F-HRchanges · EDGAR ↗
Q1 2024$270M5Apr 29, 202413F-HRchanges · EDGAR ↗
Q4 2023$203M4Jan 25, 202413F-HRchanges · EDGAR ↗
Q3 2023$278M10Nov 9, 202313F-HRchanges · EDGAR ↗
Q2 2023$267M6Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023Under review11May 11, 202313F-HRchanges · EDGAR ↗
Q4 2022Under review7Jan 30, 202313F-HRchanges · EDGAR ↗
Q3 2022$296M7Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$270M11Aug 11, 202213F-HRchanges · EDGAR ↗
Q1 2022$277M7May 12, 202213F-HRchanges · EDGAR ↗
Q4 2021$357M6Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$344M6Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$280M5Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$116M3May 13, 202113F-HRchanges · EDGAR ↗
Q4 2020$134M2Feb 12, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.